EVEGYN Vaginal Ovule Bioavailability Study in Healthy Female Subjects

This study focuses on a medication called EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule, a combination of three drugs: 600 mg fenticonazole nitrate, 1000 mg tinidazole, and 100 mg lidocaine. This medication is designed to combat common vaginal infections like bacterial vaginosis and candidal vulvovaginitis. The study aims to understand how this medication works in the body and how safe it is. It's being conducted with 18 healthy female participants, as the medication is intended for women's health. The results of this study could help improve treatment options for common vaginal infections. In this study, each participant receives a single dose of the medication, which is administered intravaginally. The study then measures how the body responds to each of the three drugs in the medication over a period of 72 hours. The response is measured by looking at the maximum concentration of each drug in the bloodstream and the area under the plasma concentration-time curve, which shows how the concentration of the drug changes over time. This helps researchers understand how the body absorbs and processes the medication.